{"name":"Mylan Pharmaceuticals Private Limited","slug":"mylan-pharmaceuticals-private-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQRGRqZE10blkzWTg1SnUtdFZpaUxFNzBxamV3akJnU2xEdlNnSGNKR0hCcHd6MWx6NTZsRmt6MzI0VERvUXF2OF9wX1ZOUEx1ckYxWWVIcTVhRm9FUmJlVDF0YWxhNWRycmZQUWZUOVN0MUI5NTk4aXBSdlRLbDNhX1l1eEVEOFU2LWF2STFSSGFfYW9RTk51QlM0Z3YxZVJid0VSSXRaWGdHemFla1ZGdk93?oc=5","date":"2026-02-07","type":"deal","source":"lupin.com","summary":"Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar - Lupin | Press Release - lupin.com","headline":"Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar - Lupin | Press Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQZmNVYjBMOEEtb1I0bXB4X1Y1SnFYQl9PRGUzb2N0bkhpTEljcnZ1YUwyNC1mVC1XRjhza0cyNnJZdFRmd1Z0OXhMLXpkV0szTFpXdjNySmlyOXJ1ZGczMjNKd25fd0VkOHY5TGtNd3F0bUc4cE1fakZMdG5BSExQZjFhODlidlp4VGRSWWlISGF3cXBoWE1YdkpRQmhheDTSAVZBVV95cUxQRThmdVR6dFpLSkg2b0JUNTdKbTB3aC15aXF6b1dhOHY4dU92dldoM2REM05JZ2NSbzdhdFExckVpUGM3N2dlVGNtQ3pvSVN2eS1rczFHUQ?oc=5","date":"2026-01-09","type":"patent","source":"Law360","summary":"Mylan, Aurobindo Must Face Generic Drug Price-Fixing Claims - Law360","headline":"Mylan, Aurobindo Must Face Generic Drug Price-Fixing Claims - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOMXZwcUF2eWNSaHh2MVY4SlVxN25lSVQ4c2VQS3FzYndfdGk5aWFFUXdRZGtYT0IzeEJob3hUSXVZSjlpcU5uRWRnMXBOd3JVakxpRGpLUjdxYmJISGlXN2EwaWtmaGlKTGh6dGIxQXZRSDJ3c3dxckc0MEJNZ0tuMVk1R25aUVlndlVaSTM0X2FuZnBKelpUdmZtcWNCY3JIT0pyRW56aWFRcDdoTVhFaGtZNXNxWHBZQ0dhZWVVX3luNG9yUWxoS1Y1VXRBWFFfUE0wMw?oc=5","date":"2025-10-01","type":"trial","source":"Jones Day","summary":"Federal Circuit: When and How to Patent Around Clinical Trials - Jones Day","headline":"Federal Circuit: When and How to Patent Around Clinical Trials","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-26","type":"patent","source":"The Times of India","summary":"Trump’s 100% pharma tariffs: How bad will India's pharmaceutical exports be hit? 'Low-cost generic model - The Times of India","headline":"Trump’s 100% pharma tariffs: How bad will India's pharmaceutical exports be hit? 'Low-cost generic model","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-24","type":"regulatory","source":"Business Standard","summary":"Pfizer shares gain 9% after board approves agreement with Mylan Pharma - Business Standard","headline":"Pfizer shares gain 9% after board approves agreement with Mylan Pharma","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-02-21","type":"deal","source":"CNBC TV18","summary":"Pfizer inks deal with Mylan Pharma to market Ativan and Pacitane in India - CNBC TV18","headline":"Pfizer inks deal with Mylan Pharma to market Ativan and Pacitane in India - CNBC TV18","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQT1FIQ3F4WU5Jb2Z6aElaR2tLYk1sbHpseldjZ3BtMm1wcDg2N0pLdlVTUjg3cWZhemF5SGN0S3FuRE9kMlhmRV9WVlcxci12LVh3UVFZOU95a2RGZGdxY3F0U2l4c18zbkNjVjhkdEY1VmczVnczSTRKeC1pUk95VXVKM0NVdVlfSDFHNHZKaHM4VTNGZVhfOWdLNTQ0QVRJWnpHUVY1Mk0?oc=5","date":"2021-08-10","type":"pipeline","source":"Mountain State Spotlight","summary":"Morgantown pharmaceutical plant’s fall started long ago - Mountain State Spotlight","headline":"Morgantown pharmaceutical plant’s fall started long ago","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZ21NMEZfOFM3T3d5MGtWazZiQndXWVlOeGZGa0ctMWNwNldKLVRyLW1qTnpfOWJLakNsZjNCUXVJeTQtWGt2ZGhsd0x2RVVzVEhBZzR5a01qLWdfQjlUZDFuQ0gyNFNfOWEtZWZvbHJSb2ZFd0Q0ZWVPSTVGNU44cUctOTRidGswQzVz?oc=5","date":"2020-10-09","type":"pipeline","source":"Lexology","summary":"Case Summary : Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd - Lexology","headline":"Case Summary : Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNNVNGLXhpdmNUeGxsNUxYTi0xNGxqVTJha2Z3Z3AzbGtlOWhheEsyMGxZOV9PX3ZPcHBIUExHRTl0RzhaaXc0QmxkZmUxX1RJaE9lckRVRjFKT3VvNzY3cjk4dVZXTXFGTXJveUw4VnJTZFlibHFPc0d3UXdTb3R0MWRnMGZhMTkzclUzYWtKYzdpS19DWktUNDN2ZGFsdG8?oc=5","date":"2020-05-17","type":"pipeline","source":"Healthcare Digital","summary":"Mylan unit starts commercial ops in India - Healthcare Digital","headline":"Mylan unit starts commercial ops in India","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-01-08","type":"pipeline","source":"PR Newswire","summary":"Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutica","headline":"Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQM0VMWnd5bU1FTW1nSFN5b0dSeU5saTZ6c0ttYTFyV0VoR0hSejAtSk55dzV2Z2FXSmx4R3JiMlJIUkxKMTl0SHdRQTVla09pekJtdS1oU0dzN25vRHljRXhIRGJNWmlLbk5HaWZvbFhlelN5MGh1VjhLYzk3LUJJc0p3?oc=5","date":"2017-05-26","type":"pipeline","source":"JD Supra","summary":"Mylan Institutional LLC v. Aurobindo Pharma Ltd. (Fed. Cir. 2017) - JD Supra","headline":"Mylan Institutional LLC v. Aurobindo Pharma Ltd. (Fed. Cir. 2017)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxObWRwck5JNmtqQ29xRFI0YU1xanZQaElydTNpU2pydllPSXJ5UTFQS0J5MEdacGlwbVZtWlJIVGRhSFhDTTV3ajQxUDRNS2psT0F1cXNnOGlMQnAzZ1h1dkk3QnhVNEdGbTQ3MFU5Qnl5OFlMMWYzYlhMdF9CeTJHNC1CdjE0T0pYbW5ETWVtYmNmTmRmV24tOXNB?oc=5","date":"2015-05-05","type":"pipeline","source":"Fierce Pharma","summary":"Mylan Launches Gilead Sciences' Sovaldi® Tablets in India - Fierce Pharma","headline":"Mylan Launches Gilead Sciences' Sovaldi® Tablets in India","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}